Objectives/Hypothesis. To describe the clinical features, pathogenesis, and
management of the otological complications in Churg-Strauss syndrome (CSS)
. Study Design: Retrospective review of five patients with documented CSS w
ho had otological manifestations in the later stages of CSS. Methods: The h
istory, treatment, and outcome were evaluated using office and hospital cha
rt data in these five cases. Results. In all cases, otological manifestatio
ns occurred during an advanced stage of CSS and was characterized by the pr
esence of dense aural discharge, granulomatous eosinophilic infiltration in
to mastoid and middle ear, and subacute severe to profound hearing loss. In
all cases, the recurrent aural discharge and granulomatous infiltrate was
unresponsive to conventional treatment including repeated myringotomies and
aggressive antibiotics. Systemic steroid administration resulted in a rapi
d, complete cessation of aural discharge and reversal or stabilization of h
earing loss. Otological manifestations have been stable over a range of fol
low-up from 1 to 20 years on a maintenance regimen of steroids. Conclusions
. Temporal bone involvement in CSS is rare. Surgical intervention of the te
mporal bone is relegated to complications that may include infectious masto
iditis and intracranial involvement. Recognition of the association between
CSS and otological disease is important because it is highly responsive to
systemic steroids, and early steroid treatment may prevent progression to
irreversible hearing loss, infectious otomastoiditis, or intracranial compl
ications.